Amendments & Special Instructions to the DRIVe EZ-BAA



Review solicitation here - beta.SAM.gov


Special Instructions #19 - 03/31/2022 - Please see Special Instructions 019 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002. Under these Special Instructions 019, BARDA has extended closing dates for AOIs #2, #5, and #12.


Special Instructions #18 - 01/07/2022 - Please see Special Instructions 018 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002. Under these Special Instructions 018, BARDA is now accepting abstract submissions for Funding Opportunity #13: Endotyping for Host-Directed Therapeutics and revising descriptions for funding opportunities: #8 Bringing Laboratory Testing to the Home, #9 Digital Health Tools for Pandemic Preparedness, #11a Home-based, Over-the-Counter Diagnostics for the Detection of SARS-CoV-2, and #11b Enabling Technologies to Support Home-Based Diagnostics for SARS-CoV-2 Acute Infection.


Special Instructions #17 - 11/24/2021 - Please see Special Instructions 017 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002. Under these Special Instructions 017, BARDA is now pausing submissions for Funding Opportunity #6: Beyond The Needle as part of its EZ-BAA (BAA-20-100-SOL-0002).


Special Instructions #16 - 11/10/2021 - Please see Special Instructions 016 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002. Under these Special Instructions 016, BARDA is now accepting abstract submissions for Funding Opportunity #5: the reopening of ReDirect (Repurposing Drugs in Response to Chemical Threats) as part of its EZ-BAA (BAA-20-100-SOL-0002).


Special Instructions #15 - 10/22/2021 - Please see Special Instructions 015 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002. Under these Special Instructions 015, BARDA is now accepting abstract submissions for Funding Opportunity #12: Mitigating Long-term Effects (MILE) of Respiratory Distress as part of its EZ-BAA (BAA-20-100-SOL-0002).


Special Instructions #14 - 8/25/2021 - Please see Special Instructions Special Instructions 014 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002. Under these Special Instructions 014, BARDA is now accepting abstract submissions for Area of Interest #8: Bringing Laboratory Testing to the Home, #9: Digital Health Tools for Pandemic Preparedness, #10: NGS-based Agnostic Diagnostic, #11a: Home-based, Over-the-Counter Diagnostics for the Detection of SARS-CoV-2 and 11b: Enabling Technologies to Support Home-Based Diagnostics for SARS-CoV-2 Acute Infection as part of its EZ-BAA (BAA-20-100-SOL-0002).


Special Instructions #13 - 6/30/2021 - Please see Special Instructions 013 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002. Under these Special Instructions 013, BARDA is now accepting abstract submissions for Area of Interest #7: ImmuneChip+ as part of its EZ-BAA (BAA-20-100-SOL-0002).



Special Instructions #12 - 10/22/2020 - Please see Special Instructions 012 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002. Under these Special Instructions 012, BARDA is now accepting abstract submissions for "Funding Opportunity #1: ENACT (Early Notification to Act, Control and Treat)” and "Funding Opportunity #2: Infection Severity & Solving Sepsis.” Additionally, “Funding Opportunity #4.3: Alternative Routes of Administration (AROA) for Vaccines” is now “Funding Opportunity #6: Beyond the Needle".




Special Instructions #11 - 10/1/2020 - Please see Special Instructions 011 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002. Under these Special Instructions 011, BARDA is now accepting abstract submissions for "Area of Interest #5: ReDIRECT (Repurposing Drugs In Response to Chemical Threats)" as part of its EZ-BAA (BAA-20-100-SOL-0002).


Special Instructions #10 - 7/9/2020 - Please see Special Instructions 010 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002. Under these Special Instructions 010, BARDA is adding topic #4.1-E under its temporary Funding Opportunity #4: COVID-19 as part of its EZ-BAA (BAA-20-100-SOL-0002).


Special Instructions #9 - 6/29/2020 - Please see Special Instructions 009 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002. Under these Special Instructions 009, BARDA is revising topics #4.1-D and #4.3 immediately, and extending the closing date to 2359 HRS ET on 31 October 2020 under its temporary Funding Opportunity #4: COVID-19 as part of its EZ-BAA (BAA-20-100-SOL-0002).


Special Instructions #008 / Amendment #1 - 6/4/2020 - Amendment 001 to the EZ-BAA is now included as an attachment. Amendment 001 revises Section C of the EZ-BAA.

Please also see Special Instructions 008 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002. Under these Special Instructions 008, BARDA is revising topic #4.3 immediately, and closing topic #4.4 at 1700 HRS ET on 05 June 2020 under its temporary Funding Opportunity #4: COVID-19 as part of its EZ-BAA (BAA-20-100-SOL-0002).


Special Instructions #7 - 5/12/2020 - Please see Special Instructions 007 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002. Under these Special Instructions 007, BARDA is closing topics #4.1-B and #4.1-C under its temporary Funding Opportunity #4: COVID-19 as part of its EZ-BAA (BAA-20-100-SOL-0002).


Special Instructions #6 - 4/27/2020 - Please see Special Instructions 006 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002. Under these Special Instructions 006, BARDA is adding topic #4.1-D under its temporary Funding Opportunity #4: COVID-19 as part of its EZ-BAA (BAA-20-100-SOL-0002).


Special Instructions #5 - 4/2/2020 - Please see Special Instructions 005 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002. Under these Special Instructions 005, BARDA is closing topic #4.1-A and revising topic #4.1-C under its temporary Funding Opportunity #4: COVID-19 as part of its EZ-BAA (BAA-20-100-SOL-0002).


Special Instructions #4 - 3/18/2020 - Please see Special Instructions 004 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002. Under these Special Instructions 004, BARDA is closing topic #4.2 under its temporary Funding Opportunity #4: COVID-19 as part of its EZ-BAA (BAA-20-100-SOL-0002).


Special Instructions #3 - 3/9/2020 - Please see Special Instructions 003 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002. Under these Special Instructions, BARDA is adding several new topics under its temporary Funding Opportunity #4: COVID-19 (renamed from 2019-nCoV) as part of its EZ-BAA (BAA-20-100-SOL-0002).


Special Instructions #2 - 2/15/2020 - Please see Special Instructions 002 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002. Under these Special Instructions, BARDA is adding a new topic under its temporary Funding Opportunity #4: 2019-nCoV as part of its EZ-BAA (BAA-20-100-SOL-0002).



Special Instructions #1 - 2/3/2020 - Please see Special Instructions 001 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002. Under these Special Instructions, BARDA is temporarily suspending Funding Opportunities 1-3 as part of its EZ-BAA (BAA-20-100-SOL-0002), but is pleased to announce that it is now accepting abstract submissions for Funding Opportunity #4: 2019-nCoV.
















Straightforward & Transparent Review Process




  • Streamlined broad agency announcement (“BAA”)
  • Simplified application process
  • Projects under $750,000
  • Cost-share element